Ryan Specialty Group Holdings, Inc. Class A ( (RYAN) ) has released its Q4 earnings. Here is a breakdown of the information Ryan Specialty Group Holdings, Inc. Class A presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ryan Specialty Group Holdings, Inc. is a prominent international specialty insurance firm that provides innovative insurance solutions through distribution, underwriting, product development, administration, and risk management services for brokers, agents, and carriers. In the latest earnings report for the fourth quarter of 2024, the company reported a robust revenue growth of 24.5% year-over-year, reaching $663.5 million, despite a decline in net income by 27.3% to $42.6 million. Adjusted EBITDAC saw a significant increase of 36.2% to $216 million, driven by strong revenue growth and strategic acquisitions.
Key financial highlights include an 11% organic revenue growth rate and a 28.9% increase in adjusted net income to $123.3 million, resulting in adjusted earnings per share of $0.45. For the full year 2024, Ryan Specialty achieved a 21.1% increase in total revenue to $2.52 billion, with adjusted EBITDAC up by 29.8% and adjusted net income rising by 31.4% to $493.5 million. The company’s strategic focus on mergers and acquisitions, with seven high-quality acquisitions in the year, has significantly bolstered its market share and expanded its addressable market.
Despite the decline in net income for the quarter, the company’s adjusted metrics reflect strong operational performance and strategic growth initiatives. The increased operating expenses were largely due to higher compensation linked to revenue growth, as well as acquisition-related expenses. The declaration of an increased dividend by 9.1% to $0.12 per share reflects the company’s commitment to returning capital to shareholders.
Looking ahead, Ryan Specialty is optimistic about its growth prospects for 2025, with guidance for organic revenue growth rate between 11% to 13% and adjusted EBITDAC margins between 32.5% to 33.5%. The company’s leadership expresses confidence in sustaining differentiated growth and enhancing shareholder value through continued strategic acquisitions and market expansion.
